Trulieve Cannabis Corp (TCNNF)

The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare.

The weed purveyor's latest quarter featured a net loss, but it's been worse in the past.

Congress is being lobbied to tighten regulations on hemp products throughout the U.S.

This top pot stock feels like a solid contrarian play while the weed industry is generally down.

Cannabis stocks and ETFs skyrocketed after Trump hinted at reclassifying marijuana. Tilray surged 35% in 2 days. Other top performers included Trulieve, Tilray, Curaleaf, and Canopy Growth. This shift could ease federal regulations and improve the industry's growth potential.

70% of Americans say they support cannabis use in casino resorts, according to a UNLV survey.